MIPHARM SPA
Rosa Terribile currently holds the position of QA Manager at Mipharm S.p.A. since February 2017. Previously, Rosa worked at Bayer from November 2009 to January 2017, holding roles such as QA-Validation and QA-GMP Compliance team member. Rosa's responsibilities include risk management, change control, supplier management, internal/external audits, training management, ongoing process verification, cleaning validation, CAPA management, and more. Rosa graduated with a Master's degree in Pharmaceutical Chemistry and Technology from the Università degli Studi di Pavia in 2009.
This person is not in any teams
MIPHARM SPA
Mipharm S.p.A. was born in January 1998 following the merger of Sandoz and Ciba Geigy, from which resulted the new company Novartis. Mipharm was founded by a group of ex managers coming from Novartis by mean of a spin-off of the manufacturing site located in Milan, Via Quaranta, previously owned by Sandoz. In December 2016, Mandarin Capital Partners II acquired the majority stake in Mipharm share capital. Today, Mipharm is one of the most valuable third party manufacturing and new product development sites in Italy and it claims to have four FDA approvals (Nasal Spray Solution, Oral Potent Drug, Sachet, Packaging). Mipharm has been investing significant resources to continuously improve manufacturing site qualitative standard and currently it is able to produce and to pack a huge range of products and pharmaceutical forms.